Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
BMC Health Services Research|May 12, 2016
Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in ChinaWarren Stevens, Desi Peneva, Jim Z Li, et al.
American Journal of Therapeutics|July 8, 2003
Comparison of linezolid with oxacillin or vancomycin in the empiric treatment of cellulitis in US hospitalsAngela G Vinken, Jim Z Li, Dan A Balan, et al.
Journal of Multidisciplinary Healthcare|August 18, 2020
Harnessing Real-World Data for Regulatory Use and Applying Innovative ApplicationsKelly H Zou, Jim Z Li, Joseph Imperato, et al.
Therapeutic Innovation & Regulatory Science|March 26, 2024
The Next Horizon of Drug Development: External Control Arms and Innovative Tools to Enrich Clinical Trial DataKelly H Zou, Chelsea Vigna, Aniketh Talwai, et al.
Plos One|October 8, 2013
Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfactionDebra A Schaumberg, Miki Uchino, William G Christen, et al.
Ophthalmology|April 25, 2012
Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trialShiao Hui Melissa Liew, Kelly K Nichols, Karen J Klamerus, et al.
International Journal of Clinical Practice|June 13, 2022
Prevalence, Comorbidities, and Risk Factors of Erectile Dysfunction: Results from a Prospective Real-World Study in the United KingdomJim Z Li, Terence A Maguire, Kelly H Zou, et al.
International Journal of Antimicrobial Agents|April 15, 2004
An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effectsDilip Nathwani, Jim Z Li, Dan A Balan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trialDavid Cella, Jim Z Li, Joseph C Cappelleri, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2009
Using the Rasch model to validate and enhance the interpretation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index--Disease-Related Symptoms scaleXuemei Luo, Joseph C Cappelleri, David Cella, et al.
Pageof 4